Drugs / Riciguat
last change Aug 2024 re-read 2 minutes ago

Riciguat

Developed for
pulmonary arterial hypertension
Investigated by
Philipps University Marburg · University of Giessen

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03362047 Mar 2018 → Jul 2024 pulmonary arterial hypertension University of Giessen Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Riciguat ClinicalTrials.gov intervention name — accepted as the source's own label NCT03362047